Your search returned 9 results.

Results
	1.	Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease. [electronic resource] by Kruidenier, Laurens Kuiper, Ineke van Duijn, Wim Marklund, Stefan L van Hogezand, Ruud A Lamers, Cornelis B H W Verspaget, Hein W Producer: 20031024 In: The Journal of pathology vol. 201 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. [electronic resource] by Kruidenier, Laurens Kuiper, Ineke Van Duijn, Wim Mieremet-Ooms, Marij A C van Hogezand, Ruud A Lamers, Cornelis B H W Verspaget, Hein W Producer: 20031024 In: The Journal of pathology vol. 201 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease. [electronic resource] by Meijer, Martin J W Mieremet-Ooms, Marij A C van Hogezand, Ruud A Lamers, Cornelis B H W Hommes, Daniel W Verspaget, Hein W Producer: 20070816 In: World journal of gastroenterology vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Matrix metalloproteinases and their tissue inhibitors as prognostic indicators for diagnostic and surgical recurrence in Crohn's disease. [electronic resource] by Meijer, Martin J Mieremet-Ooms, Marij A C Sier, Cornelis F M van Hogezand, Ruud A Lamers, Cornelis B H W Hommes, Daan W Verspaget, Hein W Producer: 20090312 In: Inflammatory bowel diseases vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Is perianal Crohn's disease associated with intestinal fistulization? [electronic resource] by Sachar, David B Bodian, Carol A Goldstein, Eric S Present, Daniel H Bayless, Theodore M Picco, Michael van Hogezand, Ruud A Annese, Vito Schneider, Judith Korelitz, Burton I Cosnes, Jacques Producer: 20050830 In: The American journal of gastroenterology vol. 100 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Infliximab treatment influences the serological expression of matrix metalloproteinase (MMP)-2 and -9 in Crohn's disease. [electronic resource] by Gao, Qiang Meijer, Martin J W Schlüter, Ulrike G van Hogezand, Ruud A van der Zon, Johanna M van den Berg, Marlies van Duijn, Wim Lamers, Cornelis B H W Verspaget, Hein W Producer: 20070822 In: Inflammatory bowel diseases vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Effect of the anti-tumor necrosis factor-alpha antibody infliximab on the ex vivo mucosal matrix metalloproteinase-proteolytic phenotype in inflammatory bowel disease. [electronic resource] by Meijer, Martin J Mieremet-Ooms, Marij A C van Duijn, Wim van der Zon, Annie M Hanemaaijer, Roeland Verheijen, Jan H van Hogezand, Ruud A Lamers, Cornelis B H W Verspaget, Hein W Producer: 20070607 In: Inflammatory bowel diseases vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project. [electronic resource] by Cleynen, Isabelle González, Juan R Figueroa, Carolina Franke, Andre McGovern, Dermot Bortlík, Martin Crusius, Bart J A Vecchi, Maurizio Artieda, Marta Szczypiorska, Magdalena Bethge, Johannes Arteta, David Ayala, Edgar Danese, Silvio van Hogezand, Ruud A Panés, Julian Peña, Salvador Amado Lukas, Milan Jewell, Derek P Schreiber, Stefan Vermeire, Severine Sans, Miquel Producer: 20131217 In: Gut vol. 62 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementation. [electronic resource] by van Bodegraven, Ad A Bravenboer, Nathalie Witte, Birgit I Dijkstra, Gerard van der Woude, C Janneke Stokkers, Pieter C M Russel, Maurice G Oldenburg, Bas Pierik, Marieke Roos, Jan C van Hogezand, Ruud A Dik, Vincent K Oostlander, Angela E Netelenbos, J Coen van de Langerijt, Lex Hommes, Daniel W Lips, Paul Producer: 20140930 In: Gut vol. 63 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)